Naeem Khan, MD: Ticagrelor Shines in Phase 3 THALES TrialByNaeem Khan, MDJuly 25th 2020The vice president of AstraZeneca ’s Cardiovascular and Metabolic Diseases Portfolio detailed the results from the phase 3 THALES trial, and where ticagrelor stands among other FDA approved stroke treatments.